A facile nanoaggregation strategy for oral delivery of hydrophobic drugs by utilizing acid-base neutralization reactions
- PMID: 21832541
- DOI: 10.1088/0957-4484/19/37/375104
A facile nanoaggregation strategy for oral delivery of hydrophobic drugs by utilizing acid-base neutralization reactions
Abstract
Nanonization strategies have been used to enhance the oral availability of numerous drugs that are poorly soluble in water. Exploring a facile nanonization strategy with highly practical potential is an attractive focus. Here, we report a novel facile nanoaggregation strategy for constructing drug nanoparticles of poorly soluble drugs with pH-dependent solubility by utilizing acid-base neutralization in aqueous solution, thus facilitating the exploration of nanonization in oral delivery for general applicability. We demonstrate that hydrophobic itraconazole dissolved in acid solution formed a growing core and aggregated into nanoparticles in the presence of stabilizers. The nanoparticles, with an average diameter of 279.3 nm and polydispersity index of 0.116, showed a higher dissolution rate when compared with the marketed formulation; the average dissolution was about 91.3%. The in vivo pharmacokinetic studies revealed that the nanoparticles had a rapid absorption and enhanced oral availability. The diet state also showed insignificant impact on the absorption of itraconazole from nanoparticles. This nanoaggregation strategy is a promising nanonization method with a facile process and avoidance of toxic organic solvents for oral delivery of poorly soluble drugs with pH-dependent solubility and reveals a highly practical potential in the pharmaceutical and chemical industries.
Similar articles
-
Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility.Int J Pharm. 2011 Jul 15;413(1-2):237-44. doi: 10.1016/j.ijpharm.2011.04.034. Epub 2011 Apr 21. Int J Pharm. 2011. PMID: 21540090
-
Mechanistic understanding of salt-induced drug encapsulation in nanosuspension via acid-base neutralization as a nanonization platform technology to enhance dissolution rate of pH-dependent poorly water-soluble drugs.Eur J Pharm Biopharm. 2020 Sep;154:8-17. doi: 10.1016/j.ejpb.2020.07.001. Epub 2020 Jul 4. Eur J Pharm Biopharm. 2020. PMID: 32634569
-
Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base.Eur J Pharm Biopharm. 2006 Nov;64(3):360-8. doi: 10.1016/j.ejpb.2006.05.008. Epub 2006 Jul 18. Eur J Pharm Biopharm. 2006. PMID: 16846725
-
Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.Int J Pharm. 2011 Nov 25;420(1):1-10. doi: 10.1016/j.ijpharm.2011.08.032. Epub 2011 Aug 30. Int J Pharm. 2011. PMID: 21884771 Review.
-
Nanonization strategies for poorly water-soluble drugs.Drug Discov Today. 2011 Apr;16(7-8):354-60. doi: 10.1016/j.drudis.2010.02.009. Epub 2010 Mar 3. Drug Discov Today. 2011. PMID: 20206289 Review.
Cited by
-
Dissolution improvement of electrospun nanofiber-based solid dispersions for acetaminophen.AAPS PharmSciTech. 2010 Jun;11(2):809-17. doi: 10.1208/s12249-010-9438-4. Epub 2010 May 6. AAPS PharmSciTech. 2010. PMID: 20446072 Free PMC article.
-
Tailoring Mesalazine Nanosuspension Using Chitosan Polyelectrolyte Complexes with Alginate and Alginate/Hydroxypropyl-Methylcellulose Phthalate.Pharmaceutics. 2024 Nov 21;16(12):1489. doi: 10.3390/pharmaceutics16121489. Pharmaceutics. 2024. PMID: 39771469 Free PMC article.
-
Enhanced transdermal delivery of meloxicam by nanocrystals: Preparation, in vitro and in vivo evaluation.Asian J Pharm Sci. 2018 Nov;13(6):518-526. doi: 10.1016/j.ajps.2017.10.004. Epub 2017 Dec 7. Asian J Pharm Sci. 2018. PMID: 32104426 Free PMC article.
-
Melanin Nanoparticles Obtained from Preformed Recombinant Melanin by Bottom-Up and Top-Down Approaches.Polymers (Basel). 2023 May 19;15(10):2381. doi: 10.3390/polym15102381. Polymers (Basel). 2023. PMID: 37242955 Free PMC article.
-
Elucidating the in vivo fate of nanocrystals using a physiologically based pharmacokinetic model: a case study with the anticancer agent SNX-2112.Int J Nanomedicine. 2015 Mar 31;10:2521-35. doi: 10.2147/IJN.S79734. eCollection 2015. Int J Nanomedicine. 2015. PMID: 25848269 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources